Browse Related Topics For:

Hatch-Waxman

222
Pharmaceutical Industry
217
Patents
210
Generic Drugs
201
Pharmaceutical Patents
187
Patent Infringement
173
Patent Litigation
151
ANDA
146
Prescription Drugs
114
FDA
78
Patent-in-Suit
46
Intellectual Property Protection
39
SCOTUS
35
Reverse Payment Settlement Agreements
34
FTC
32
FTC v Actavis
28
Mylan Pharmaceuticals
26
Teva Pharmaceuticals
21
Popular
20
Actavis Inc.
20
Personal Jurisdiction
19
Biosimilars
19
BPCIA
19
Pay-For-Delay
17
Antitrust Litigation
16
Inter Partes Review (IPR) Proceeding
15
Sandoz
15
Watson Pharmaceuticals
13
America Invents Act
13
Appeals
13
Patent Trial and Appeal Board
12
AstraZeneca
10
Anti-Competitive
10
Apotex
10
Settlement
9
Biologics
9
Merck
9
Prior Art
9
Sherman Act
8
Claim Construction
8
Eli Lilly
8
Endo Pharmaceuticals
8
GlaxoSmithKline
8
Patent Applications
8
Rule-of-Reason Analysis
8
Safe Harbors
8
Sandoz v Amgen
8
USPTO
7
Amgen
7
Cephalon
7
DaimlerChrysler v Bauman
7
Declaratory Judgments
7
Novartis
7
Obviousness
7
Otsuka Pharmaceutical
6
Allergan Inc
6
Bayer
6
Commercial Marketing
6
Corporate Counsel
6
FDA Approval
6
FDCA
6
Hospira
6
Infringement
6
Motion to Dismiss
6
Orange Book
6
Patent Invalidity
6
Preliminary Injunctions
6
Summary Judgment
6
Warner Chilcott
5
Antitrust Violations
5
Class Action
5
Classen Immunotherapies
5
No-AG Agreement
5
On-Sale Bar
5
Patent Dance
5
Patent Reform
5
Preemption
5
Roxane Laboratories
5
Takeda Pharmaceuticals
5
Teva v Sandoz
4
Antitrust Provisions
4
Discovery
4
Elan Pharmaceuticals
4
Federal Rule 12(b)(6)
4
Induced Infringement
4
Jurisdiction
4
Labeling
4
Manufacturers
4
Minimum Contacts
4
Patent-Eligible Subject Matter
4
Pleading Standards
4
Product Hopping
4
Putative Class Actions
4
Reverse Payments
4
Shire Development v Watson
4
Specific Jurisdiction
4
Standard of Review
4
Standing
4
Subject Matter Jurisdiction
3
aBLA
3
Allergan v Sandoz
3
Article III
3
Aurobindo Pharmaceuticals
3
Biologics Price Competition and Innovation Act of 2009
3
Biotechnology
3
Competition
3
De Novo Standard of Review
3
Disgorgement
3
Dismissals
3
Exclusivity
3
Failure To Warn
3
Healthcare
3
Hedge Funds
3
Innovation Act
3
Life Sciences
3
Noninfringement
3
Notice Requirements
3
Par Pharmaceutical
3
Patent Trolls
3
Product Exclusivity
3
Spectrum
3
TC Heartland LLC v Kraft Foods
3
Unfair Competition
2
Amarin
2
Brand
2
Burden of Proof
2
CA Supreme Court
2
Canada
2
Cartwright Act
2
Certiorari
2
DaimlerAG
2
Damages
2
Direct Purchasers
2
Disclosure Requirements
2
Doctrine of Equivalents
2
Estoppel
2
EU
2
Forest Laboratories
2
Forum Selection
2
Forum Shopping
2
Fresenius
2
Generic
2
Genzyme
2
Injunctions
2
Innovation
2
Intellectual Property Litigation
2
Licensing Rules
2
Medicare Modernization Act
2
Method Claims
2
Monopolization
2
Motion To Stay
2
Mutual Pharmaceuticals v Bartlett
2
Nexium
2
Non-Practicing Entities
2
Orphan Drugs
2
OxyContin
2
Pfizer
2
PLIVA v Mensing
2
Presumption of Validity
2
Proposed Regulation
2
Sanofi
2
Settlement Agreements
2
Sham Litigation Exception
2
SmithKline Beecham
2
SNDAs
2
State of Incorporation
2
Trade Agreements
2
Venue
2
Written Descriptions
1
Abbott Laboratories
1
AbbVie
1
Abuse of Process
1
Affordable Care Act
1
Amicus Briefs
1
AMP v Myriad
1
Annual Reports
1
Antibiotics
1
Antitrust Conspiracies
1
Antitrust Division
1
Antitrust Injuries
1
Antitrust Standing
1
Attorney Disbarrment
1
Attorney-Client Privilege
1
Australia
1
Automatic Stay
1
Balancing Test
1
Bifurcation
1
Biofuel
1
Biogen Idec
1
Biopharmaceutical
1
Bipolar Disorder
1
Boehringer
1
Bowman v Monsanto
1
Bristol-Myers Squibb
1
Broadest Reasonable Interpretation Standard
1
Burden-Shifting
1
But For Causation
1
CAFA
1
Cancer
1
Causation
1
Chevron Deference
1
China
1
China FDA
1
Cipro
1
Cisco v CommilUSA
1
Claim Preclusion
1
Class Certification
1
Clear and Convincing Evidence
1
Clear Error Standard
1
Clinical Trials
1
CLS Bank v Alice Corp
1
Coca Cola
1
Collateralized Debt Obligations
1
Combination Products
1
Comment Period
1
Compliance
1
Congressional Committees
1
Consent Order
1
Consideration
1
Contraceptives
1
Controlled Substances Act
1
Counterclaims
1
Covered Business Method Patents
1
Covered Business Method Proceedings
1
Cuozzo Speed Technologies
1
Dart Cherokee Basin Operating Co. v. Owens
1
Data Protection
1
DEA
1
Death Penalty
1
Dell
1
Denial of Certiorari
1
Design Defects
1
Design Patent
1
Dirks v SEC
1
Discovery Schedule
1
DNA
1
Drug Approvals
1
Drug Compounding
1
Drug Pricing
1
Drug Safety
1
Duty to Deal
1
Duty to Update
1
eBay
1
Emerging Markets
1
Employer Mandates
1
Enforcement
1
Enforcement Actions
1
Enforcement Statistics
1
EPA
1
European Patent Office
1
Ex Partes Reexamination
1
Exemptions
1
Expert Testimony
1
Exports
1
Extrinsic Evidence
1
Fair Market Value
1
False Advertising
1
Federal Jurisdiction
1
Federal Rule 12(b)(1)
1
Federal Rules of Civil Procedure
1
Financial Crisis
1
Foreign Corporations
1
Foreign Defendants
1
Forum
1
Forum Non Conveniens
1
Fraud
1
General Jurisdiction
1
Goodyear
1
Hague Convention
1
Healthcare Costs
1
Human Genes
1
India
1
Injury-in-Fact
1
Innovator Liability
1
Insider Trading
1
Integra
1
Inter Partes Reexamination
1
InterDigital Communications v ITC
1
Internal Investigations
1
Inventions
1
ITC
1
Jazz Pharmaceuticals
1
Joinder
1
Judge Stark
1
Jury Verdicts
1
Justiciable Controversy
1
KBR (formerly Kellogg Brown & Root)
1
Laches
1
Lanham Act
1
Leave to Amend
1
License Agreements
1
Loss Causation
1
Manufacturing Defects
1
Market Manipulation
1
Marketing
1
Markman Hearing
1
Material Misrepresentation
1
Mayo v. Prometheus
1
Medical Devices
1
Medical Research
1
Misrepresentation
1
Monsanto
1
Morgan Stanley
1
Motion for Reconsideration
1
Motion to Amend
1
Myriad
1
New Trial
1
Nintendo
1
Non-Appealable Decisions
1
Off-Label Use
1
Omissions
1
Omnicare v Laborers District Council
1
Opioid
1
Oral Argument
1
Out-of-State Companies
1
Patent Agent Privilege
1
Patent Assertion Entities
1
Patent Exhaustion
1
Patent Term Adjustment
1
Patent Term Extensions
1
Patent-Misuse
1
Patentability Search
1
Pending Legislation
1
Permanent Injunctions
1
Personal Benefit
1
Petition For Rehearing
1
PHRMA
1
Physical Presence Test
1
Pleadings
1
POM Wonderful
1
Post-Grant Review
1
Presidential Elections
1
Price Manipulation
1
Prilosec
1
Principal Place of Business
1
Prioritized Examination
1
Privilege Waivers
1
Proctor & Gamble
1
Product Defects
1
Product Labels
1
Product of Nature Doctrine
1
Professional Conferences
1
Prometheus
1
Proposed Amendments
1
Public Meetings
1
Quality Control Plan
1
RanBaxy
1
Registration Requirement
1
Regulatory Agenda
1
Regulatory Standards
1
Reissue Patents
1
Remand
1
Removal
1
Research and Development
1
Restraining Orders
1
Retailers
1
Reversal
1
RICO
1
Ripeness
1
ROI
1
Royalties
1
Rule 26
1
Rulemaking Process
1
Sales Contracts
1
Scienter
1
Scope of Discovery Requests
1
Section 337
1
Single Occurrence
1
Standard of Proof
1
State Law Tort Claims
1
STRONG Patents Act
1
Supplemental Examination
1
Supply Chain
1
Tolling
1
Trade Policy
1
Trademark Infringement
1
Transfer of Venue
1
TRIPS Agreement
1
TRO
1
Tyco
1
Uniform Commercial Code (UCC)
1
USDA
1
Vacated
1
Vaccinations
1
Validity
1
Valuation
1
Veterinarians
1
Veterinary Products
1
Warning Labels
1
White Collar Crimes
1
WIPO
1
Work Product Privilege
1
World Intellectual Property Organisation